(2S,5R)-1,5-dimethylpyrrolidine-2-carboxylic acid, 95.0%, 250mg

2,1,3-benzoxadiazole-5-carbaldehyde, 95.0%, 250mg

5,6-Dimethyl-2-oxo-1,2-dihydropyridine-3-carbonitrile, 95.0%, 5g

1-BENZYL-4-(2-CHLOROPYRIDIN-3-YL)PIPERIDINE-4-CARBONITRILE, 95.0%, 250mg

2-(Benzo[b]thiophen-2-yl)acetic acid, 95.0%, 250mg

METHYL 3-(PYRROLIDINE-3-YL)PROPANOATE HCL, 95.0%, 100mg

N-methyl-2-pyrrolidin-1-ylethanamine dihydrochloride, 95.0%, 500mg

5'-Bromo-5-methyl-[2,2']bipyridinyl, 97.0%, 5g

2,4-Dichloro-7-methoxyquinoline, 95.0%, 1g

5-Bromo-3-(difluoromethyl)pyridin-2-amine, 98%, 1g

tert-Butyl 3-(2,4-difluorophenyl)-3-hydroxyazetidine-1-carboxylate, 98%, 1g

4-BROMO-3-FLUORO-N-(4-(TRIFLUOROMETHYL)PYRIDIN-2-YL)BENZAMIDE, 95.0%, 250mg

GC capillary column ROTI®Cap-1, 50 m, 0.25 mm, 0.25 µm, 1 Piece(s)